MedTrace Logo

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

NCT06928337 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-08-07

No results posted yet for this study

Summary

This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.

Conditions

  • Fertility Disorders

Interventions

DEVICE

AI evaluation of oocytes.

AI evaluation of oocytes inside a time-lapse incubator.

Sponsors & Collaborators

  • Fairtility

    lead INDUSTRY

Principal Investigators

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-05-01
Completion
2026-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06928337 on ClinicalTrials.gov